share_log

富邦股份最新公告:拟8750万元收购湘渝生物70%股权

Latest announcement of Fubon shares: plans to acquire 70% stake in Xiangyu Bio with 87.5 million yuan

證券之星 ·  Dec 10, 2021 07:06

Fubon Co., Ltd. announced that it intends to acquire a 70% stake in Xiangyu Biotechnology (Yueyang) Co., Ltd. for 87.5 million yuan.

The chairman of the company is Wang Renzong. Mr. Wang Renzong: Chinese nationality, no permanent residence abroad, born in 1964, master's degree. He served as the director of the technical development department of Zhongshan Yongli Daily Chemical Co., Ltd from July 1990 to May 1994, and the general manager of Zhongshan Green Wind Chemical products Co., Ltd from May 1994 to October 1995. he served as executive director, general manager and deputy general manager of Yingcheng Fubon Technology Co., Ltd from November 1995 to January 2007, chairman of the company from January 2007 to the present, and general manager of the company since May 20, 2015. He has been the executive director and general manager of Wuhan Nuo Weikai since October 2010, the supervisor of Wuhan Heda Technology Co., Ltd since August 2015, and the chairman of Hubei Yangdao Ecological Agriculture Co., Ltd since September 2015. he has been the executive director and general manager of Wuhan Horui New Fertilizer Co., Ltd since January 2016, and the director of Wuhan Pangu Digital testing Co., Ltd since December 29, 2016. Since May 27, 2017, he has been the Executive Director and General Manager of Wuhan Sutu data Technology Co., Ltd., and has been the Executive Chairman and General Manager of Wuhan Luo Union Agricultural Technology Co., Ltd since June 13, 2017. He has been the director of Israel Saturas since August 2018, the director of Israel Fruitspec since October 2019, and the chairman of Wuhan Heda Technology Co., Ltd since January 2020. The current chairman and general manager of the company.

This article is compiled by the Securities Star data Center according to the public data and does not constitute investment opinions or suggestions. If you have any questions, please contact us.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment